Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1983:81:229-45.

Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS)

E Okun, G P Johnston, I Boniuk, N Arribas, R F Escoffery, M G Grand
Comparative Study

Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS)

E Okun et al. Trans Am Ophthalmol Soc. 1983.

Abstract

Over 2500 xenon arc-treated eyes which would have qualified for inclusion in the DRS were reviewed in the format of the DRS. When comparable risk groups were compared, the results of treatment were even more favorable than reported in the DRS without the severe complications attributed to xenon treatment in the DRS. A critical analysis of the DRS gives clues for the greater amount of visual loss found with xenon than argon in the DRS. Since these complications may be avoidable in some cases and since xenon has been shown to be at least as effective as argon, it should continue to be used in the treatment of PDR.

PubMed Disclaimer

References

    1. Ann Ophthalmol. 1982 Apr;14(4):362-3 - PubMed
    1. Surv Ophthalmol. 1975 Mar-Apr;19(5):267-86 - PubMed
    1. Am J Ophthalmol. 1971 Aug;72(2):299-321 - PubMed
    1. Am J Ophthalmol. 1971 Feb;71(2):437-45 - PubMed
    1. Br J Ophthalmol. 1963 Sep;47:539-41 - PubMed

Publication types

LinkOut - more resources